Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04614259Unknown
Randomised, single-blind trial of bupivacaine in perioperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Postoperative opioid consumption at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04614259.